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Background. Hepatocellular carcinoma (HCC) arising from the end 
stages of liver cirrhosis is a fair indication for liver transplantation (LT). 
To pathologically investigate the multicentric occurrence of relatively 
early-staged HCC in cirrhosis, we studied whole explanted livers. 
Methods. Fourteen explanted livers from patients undergoing living 
donor LT (LDLT) were examined. The stage of the HCCs was judged to 
be within the Milan criteria (M-C; a single HCC less than 5 cm or 3 
HCCs less than 3 cm). Histological examination was performed using 
serially sectioned specimens 5-7 millimeters in width. Characterization 
of preoperatively detectable and undetectable lesions was also 
performed. Results. In 9 patients (64.3%), a total of 34 nodules were 
found after whole liver histological examination (WLHE). In 5 patients 
(31%), the results exceeded the M-C. The characteristics of undetectable 
HCCs included a minute (median size 6 mm), well-differentiated 
appearance (80%), with indistinct margins (85.3%), and without 
vascular invasion (94%). There was no recurrence in any patients at the 
time of follow up (median follow-up period, 30.1 months). Conclusions. A 




multicentric occurrence of HCCs was demonstrated in cirrhotic livers with HCCs 
within the M-C. Undetectable HCCs in cirrhotic livers may have no impact on 
recurrence after LT. 
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Patients with hepatocellular carcinoma (HCC) are a 
therapeutic challenge, since most tend to have chronic hepatitis or cirrhosis, 
which often develops into multicentric HCCs (1, 2). Liver transplantation 
(LT) is indicated as the treatment of choice in selected HCC patients (3-6). In 
1996, Mazzaferro and his colleagues proposed criteria for indications of LT 
for HCC, referred to as the Milan criteria (M-C) (7). The M-C consists of the 
following: solitary nodules 5 cm in size or 3 nodules 3 cm for multinodular 
HCC, no distant metastasis, and no evidence of vascular involvement. These 
factors are determined by preoperative hepatic imaging modalities. In order 
to investigate the real spread of HCC, whole liver examination is warranted. 
However, most of the previously reported whole liver examinations were 
performed using livers obtained through autopsy (e.g., (8)).Moreover, in other 
studies in which incidental HCC was detected on the explanted liver, 
histological examination was performed only for those nodules deemed 
suspicious by macroscopic examination (9-16). Thus there has not been 
sufficient investigation of HCCs in the whole explanted liver. 
In the present study, we used whole liver histological 




examination (WLHE) of transplantation explants. Clinically, these livers 
contained relatively early stage HCC within the M-C. Therefore, precise 
existence of HCCs in a cirrhotic liver with early staged HCC could be 
determined. The detectability and characterization of preoperatively 
undetectable HCCs was also examined.  
 
Patients and Methods 
Patients. Between August 1997 and December 2006, 62 LDLTs were 
performed at our center. In the early years, we performed LDLT mostly in 
patients with biliary atresia with parental donors. Beginning in November 
2000, however, we performed LDLT on 21 patients with cirrhotic livers who 
showed signs of HCC within the M-C based on multidetector computed 
tomography scanning (MDCT) and magnetic resonance imaging (MRI) done 
within 1 month before transplant. Of these, 14 explanted livers underwent 
WLHE retrospectively and prospectively by remnant whole explanted liver. 
This study was approved by the local Institutional Review Board, and 
written informed consent was obtained from all patients. 
Patient characteristics.  All 14 patients had liver cirrhosis classified as B or C 




stage by Child-Pugh classification. The etiology in these cases was hepatitis 
C virus (HCV) infection in 8 patients and hepatitis B virus (HBV) in 6 
patients. There were 6 females and 8 males, with a median age of 57 years 
(range, 48–61 years). The median values of alpha-fetoprotein (AFP) and 
protein-induced vitamin K antagonists II (PIVKAII)) were 30.25 ng/ml 
(range, 0.8-806.1) and 23 g/ml (range, 6-247). The clinical characteristics of 
the 14 patients are summarized in Table 1.  
Liver transplantation and preoperative therapy for HCC.  In all 14 patients, 
LDLT had been performed using a right lobe graft in 11 patients and a left 
lobe graft in 3 patients. The median follow-up period was 30.1 months (range, 
0.53-48.5 months). In 11 patients (78.5%), pretreatment for HCC was performed prior 
to liver transplantation, which consisted of chemolipiodolization in 6 cases, 
radiofrequency ablation (RFA) or percutaneous ethanol injection therapy (PEIT) in 4 
cases, and chemolipiodolization with PEIT in 1 case. Based on the imaging findings, 
all HCCs were considered to be within the M-C. 
Whole liver histological examination (WLHE).  After explantation, the cirrhotic 
livers were fixed in formalin for 48 hours. The livers were then sectioned at 
5-7 mm intervals, and each section was carefully inspected and mapped. All 




sections were embedded in paraffin, and all slides were made from the 
paraffin-embedded material and routinely stained with hematoxylin and 
eosin. The median total number of slides for each patient was 116.5 (range, 
64-185 slides). All slides were examined by an experienced pathologist 
(co-author S.O.). The pathological diagnoses and analyses were made 
according to the fourth edition of The General Rules for the Clinical and 
Pathological Study of Primary Liver Cancer, published by the Liver Cancer 
Study Group of Japan (LCSGJ).  
Statistical analysis.  A statistical comparison of categorical variables was 
performed using the Mann-Whitney U test and Chi-square (2) test. Results 
were considered statistically significant when the p values were less than 
0.05.   
 
Results  
At the time of LDLT, there was no evidence of extrahepatic 
cancer spread in any of the patients. Preoperative imaging findings showed 4 
patients with solitary HCC, 5 patients with double HCCs, 1 patient with 
triple HCCs, and 4 patients with no viable HCCs. In 3 patients, viable HCCs 




had completely disappeared by the time of the preoperative treatment. Eight 
patients had a local recurrence or another new lesion in the liver based on 
imaging before LDLT. All patients met the M-C with a solitary nodule 5 cm 
in size or 3 nodules 3 cm for multi-nodular HCC. 
   
Detection of HCCs by WLHE.  In 9 patients (64.3%), undetectable nodules 
were found after WLHE, and 4 patients (28.6%) had preoperatively 
detectable nodules but no new lesions (Fig. 1). In 9 cases, small HCCs that 
could not be detected by the current imaging modalities were identified only 
by pathological examination. One patient (7.1%) (case 12) had a decreased 
number of HCCs compared to the number determined from preoperative 
imaging. The distribution of preoperatively undetectable nodules, which was 
based on segmental anatomy of the liver, was as follows: 4 nodules in 
segment 2, 4 nodules in segment 3, 7 nodules in segment 4, 1 nodule in 
segment 5, 6 nodules in segment 6, 3 nodules in segment 7, and 9 nodules in 
segment 8 (Fig.1). After WLHE, 5 out of the 14 patients (35.7%) were beyond 
the M-C. When we compared the results for the number and largest size of 
HCCs between imaging and WLHE, the largest size of HCCs was not altered 




by WLHE, but the number of HCCs was increased by WLHE (Fig. 2). This 
was because small HCCs that could not be preoperatively detected by 
imaging were found in the cirrhotic liver by whole liver investigation.  
 
Characteristics of preoperatively detectable HCCs.  A total of 49 nodules were 
found by WLHE (Table 2). Fifteen nodules were found through preoperative 
images taken after histological examination, but 2 nodules detected 
preoperatively were not found in the explanted liver after WLHE. The 
median diameter of the 15 preoperatively detectable HCCs was 18 mm 
(range, 10-50 mm). There were 7 well-differentiated HCCs (46.7%) and 8 
moderately differentiated HCCs (53.3%). The preoperatively detectable 
nodules showed expansive growth (11/15; 73.3%) with fibrous capsules (60%) 
(Table 2). Only two nodules (13.3%) showed microscopic vascular invasion 
surrounding the main tumor in the detectable HCCs.  
 
Characteristics of preoperatively undetectable HCCs.  Thirty-four HCCs that 
were undetectable preoperatively were found by WLHE (Table 2). The 
median diameter of the nodules was 6 mm (range, 2-15 mm). The 




undetectable nodules consisted of 25 well-differentiated HCCs (73.5%), 9 
moderately differentiated HCCs (26.5%), and no poorly differentiated HCCs. 
The characteristic features of the preoperatively undetectable nodules 
included infiltrative growth (29/34; 85.3%), absence of fibrous capsules 
(32/34; 94.1%), and absence of microscopic vascular invasion (32/34; 94.1%).  
 
Pathological comparison of preoperatively undetectable and detectable HCCs.   By 
comparing the pathological features of undetectable and detectable HCC 
based on the preoperative imaging results, we examined the relationship 
between tumor size and each of tumor differentiation, tumor growth, and the 
presence of fibrous capsules (Fig. 3-5). No significant difference in 
differentiation or growth was found between the preoperatively detectable 
and undetectable tumor size. However, we found significant differences in 
the presence of fibrous capsules between the undetectable and detectable 
HCCs (Fig 4).  
 
Recurrence of HCCs.   In the follow-up period (median follow-up, 30.1 months), 
there was no recurrence in any patient after LDLT.  




Discussion   
In this study, we demonstrated a discrepancy in the number of 
HCCs determined from preoperative imaging studies and the number 
determined from histological measurements using WLHE. It is especially 
important to note that multicentric HCCs were diffusely present in the 
end-stage cirrhotic liver, which is clinically significant since local therapy for 
only those HCCs that are detectable might not be a practical curative 
procedure in such cirrhotic livers. In addition, this study demonstrated that 
even HCCs within the M-C, which are usually regarded as early HCCs, can 
coincide with much earlier HCCs in the severely cirrhotic liver. This finding 
has not been demonstrated in autopsied livers from patients who died of 
advanced HCC. 
In the present study, the accuracy of preoperative diagnosis for 
HCC was 28.6%, which was rather low compared to other reports (9-16). 
However, other studies used histological examination only for those nodules 
that were suspicious based on imaging findings, and not for the whole liver. 
Moreover, MDCT tends to overdiagnose HCC, with a false-positive diagnosis 
rate as high as 8-11.8% (11, 12). In addition, in a previous study MDCT could 




detect only 61% of lesions smaller than 2 cm and 93.6% of lesions 2 cm or 
larger (12). Since our study demonstrated that the median diameter of 
preoperatively undetectable nodules was 6 mm (range, 2-15 mm), the 
overlooked lesions in previous studies were definitely below the detectable 
range of CT.  
Of the 14 patients preoperatively within the M-C, undetectable 
HCCs were found in 9 patients (64.3%), with the result that 5 patients 
(35.7%) exceeded the M-C after WLHE, mainly due to the increased number 
of HCCs. The diameters of the largest HCCs determined from WLHE were 
identical to preoperative measurements. Therefore, current imaging 
modalities, such as MDCT, are good at evaluating the size of viable large 
HCCs, but not for determining the number of small HCCs. The reason the 
small HCCs were not detected by the current imaging modalities might be 
that they were characterized by an absence of fibrous capsules and an 
unclear border between the cancerous lesions and normal liver tissue. 
Another possible reason for the failure of the imaging methods to detect 
small HCC might be that the blood supply to the early HCC came more from 
the portal vein than the hepatic artery as in the case of advanced HCC. The 




distribution of undetectable HCCs did not show any special features; i.e., 
undetectable HCCs could be found in any segment in the cirrhotic liver, 
implying that MDCT did not have blind areas.  
In this study, there was no recurrence of HCCs after LT during 
the median follow-up period of 30.1 months, although 2 patients showed 
vascular invasion in the explanted livers by microscopic examination. Thus, 
HCCs in cases of advanced cirrhotic liver could be a multicentric 
phenomenon, and undetectable HCCs might not affect the survival rate after 
LT. Therefore, in the era of MDCT, the M-C would seem to be too strict a set 
of criteria for determining whether or not LT is indicated (17-20). In other 
words, if we follow the M-C as an indication of LT for HCC, the recurrence 
rate of HCC should be very much minimal.   
In conclusion, HCCs in the severely cirrhotic liver might be 
characterized by multicentric occurrence. In this study, there were no 
recurrent HCCs after LDLT. Thus, preoperatively undetectable HCCs might 
not be associated with recurrence of HCC after LDLT. However, a high rate 
of recurrence can be expected when local therapy is performed for HCC, even 
with early-stage HCC, as determined by the M-C.  
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Table 1. Clinical characteristics of 14 patients with cirrhosis and 
hepatocellular carcinoma 
 
    
Age (year) (median, range) 57 (48-61) 
Sex (M/F) 8/6 
Cause of cirrhosis  
   HBV  6 
   HCV 8 
Child-Pugh classification  
   B 5 
   C 9 
Alpha-fetoprotein (<10/10-100/>100 ng/ml) 3/7/3 
PIVKAII (<40/40> μg/ml)  8/6 
Pretransplantation treatment  
   Chemolipiodolization 6 
   PEIT or RFA 4 
   PEIT + Chemolipiodolization 1 
   none 3 
 
 
PIVKAII: protein-induced vitamin K antagonists II. 













Table 2. The characteristics of HCC on preoperative imaging study and 
postoperative histological study. 
 
 
        
  HCC on imaging (n=15) HCC only on WLHE (n=34)   
Diameter (median, range)(mm) 18 (10-50) 6 (2-15) p=0.0000006
Differentiation    
   Well 7 (46.7%) 25 (73.5%) N.S 
   Moderate 8 (53.3%) 9 (26.5%) N.S 
   Poorly 0 0  
Fibrous capsule 9 (60.0%) 2 (5.9%) p=0.000028 
Growth    
   Expansive growth 11 (73.3%) 5 (14.7%) N.S 
   Infiltrative growth 4 (26.7%) 29 (85.3%) N.S 
Microvascular invasion 2 (13.3%) 2 (5.9%) N.S 
 
 



































































Fig. 1. Detection of hepatocellular carcinoma using preoperative imaging and postoperative whole liver 
● viable HCC: hepatocellular carcinoma,  
○ Preoperative treatment with no viable HCC;  PEIT: percutaneous ethanol injection therapy, RFA: radiofrequency ablation. 
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Fig. 3. The relationship between differentiation and size 
HCC found only on WLHE  
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Fig. 4. The relationship between fibrous capsule and size 
p = 0.000028 
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HCC found on imaging 














Fig. 5. The relationship between growth and size 
Eg: Expansive growth; Ig: Infiltrative growth 
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Fig. 1. Detection of hepatocellular carcinoma using preoperative imaging 
and postoperative whole liver histological examination 
 
Fig 2. The relationship of in size and in number between imaging and WLHE 
 
Fig. 3. The relationship between differentiation and size 
 
Fig 4. The relationship between fibrous capsule and size 
 
Fig 5. The relationship between growth and size 
Eg: Expansive growth; Ig: Infiltrative growth 
 
 
 
 
 
 
 
